{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:53:55Z","timestamp":1787961235752,"version":"build-2784847793"},"reference-count":116,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020728","name":"Fundaci\u00f3n Gonzalo R\u00edo Arronte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.heliyon.2024.e29979","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T11:58:38Z","timestamp":1714564718000},"page":"e29979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of multitarget drugs on the expression of cocaine-induced locomotor sensitization in male rats: A comparative study"],"prefix":"10.1016","volume":"10","author":[{"given":"Susana","family":"Barbosa-M\u00e9ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1787-1657","authenticated-orcid":false,"given":"Alberto","family":"Salazar-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e29979_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1741-7015-9-119","article-title":"Novel pharmacotherapeutic treatments for cocaine addiction","volume":"9","author":"Shorter","year":"2011","journal-title":"BMC Med."},{"key":"10.1016\/j.heliyon.2024.e29979_bib2","first-page":"347","article-title":"Pharmacotherapy treatment of stimulant use disorder","volume":"11","author":"Liu","year":"2021","journal-title":"Ment HealthClin"},{"key":"10.1016\/j.heliyon.2024.e29979_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.882491","article-title":"Current Trends and Perspectives in the Immune therapy for substance Use disorders","volume":"13","author":"Vasiliu","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e29979_bib4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.drudis.2019.07.009","article-title":"Immunotherapy for treating methamphetamine, heroin, and cocaine use disorders","volume":"25","author":"Xiaoshan","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.heliyon.2024.e29979_bib5","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3390\/vaccines10060860","article-title":"Vaccines against drug abuse-are We there yet?","volume":"10","author":"Bloom","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.heliyon.2024.e29979_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.800245","article-title":"Cocaine-induced locomotor activation differs across Inbred mouse Substrains","volume":"13","author":"Gaines","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e29979_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120098","article-title":"Current status of vaccines for substance use disorders, A brief review of human studies","volume":"434","author":"Truong","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.heliyon.2024.e29979_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/YCO.0000000000000518","article-title":"Medications to treat cocaine use disorders, current options","volume":"32","author":"Buchholz","year":"2019","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e29979_bib9","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1007\/s11606-019-05074-8","article-title":"Pharmacotherapy for cocaine Use disorder-a Systematic review and Meta-analysis","volume":"34","author":"Chan","year":"2019","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.heliyon.2024.e29979_bib10","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2174\/156802606778522131","article-title":"Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence","volume":"6","author":"Bubar","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e29979_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0079-6123(08)00916-3","article-title":"Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse","volume":"172","author":"Bubar","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.heliyon.2024.e29979_bib12","first-page":"576","article-title":"Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding","volume":"27","author":"Fletcher","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.heliyon.2024.e29979_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00213-003-1509-8","article-title":"On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization","volume":"169","author":"Vanderschuren","year":"2003","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.heliyon.2024.e29979_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0079-6123(08)00919-9","article-title":"Dopamine\/serotonin releasers as medications for stimulant addictions","volume":"172","author":"Rothman","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.heliyon.2024.e29979_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1369-1600.2008.00138.x","article-title":"Norepinephrine and stimulant addiction","volume":"14","author":"Sofuoglu","year":"2009","journal-title":"Addict Biol"},{"key":"10.1016\/j.heliyon.2024.e29979_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/1570159X13666150121225659","article-title":"The Involvement of norepinephrine in behaviors related to psychostimulant addiction","volume":"13","author":"Zaniewska","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.pbb.2008.08.027","article-title":"Cocaine conditioning, reversal by autoreceptor dose levels of 8-OHDPAT","volume":"91","author":"Carey","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.heliyon.2024.e29979_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1196\/annals.1369.039","article-title":"Alpha-noradrenergic receptors modulate the development and expression of cocaine sensitization","volume":"1074","author":"Jim\u00e9nez-Rivera","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.heliyon.2024.e29979_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(99)00926-7","article-title":"Long-term blockade of the expression of cocaine sensitization by OND, a 5-HT (3) receptor antagonist","volume":"394","author":"King","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-2999(02)02036-8","article-title":"The effects of continuous 5-HT(3) receptor antagonist administration on the subsequent behavioral response to cocaine","volume":"449","author":"King","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00008877-199712000-00004","article-title":"Stimulation of serotonin (5-HT)1A receptors attenuates the locomotor, but not the discriminative, effects of amphetamine and cocaine in rats","volume":"8","author":"Przegali\u00f1ski","year":"1997","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00213-010-1996-3","article-title":"Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats","volume":"213","author":"Zayara","year":"2011","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.heliyon.2024.e29979_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuropharm.2015.09.031","article-title":"Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice","volume":"101","author":"Zhang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.heliyon.2024.e29979_bib24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1124\/jpet.112.195156","article-title":"The serotonin 2C receptor antagonist SB 242084 exhibits abuse-related effects typical of stimulants in squirrel monkeys","volume":"342","author":"Manvich","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.heliyon.2024.e29979_bib25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1037\/a0014592","article-title":"Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model","volume":"123","author":"Nic Dhonnchadha","year":"2009","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e29979_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00213-010-2071-9","article-title":"Blockade of 5-HT2A receptors in the medial prefrontal cortex attenuates reinstatement of cue-elicited cocaine-seeking behavior in rats","volume":"213","author":"Pockros","year":"2011","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.heliyon.2024.e29979_bib27","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1017\/S1461145714000856","article-title":"Effects of the 5-HT2C receptor agonist CP809101 in the amygdala on reinstatement of cocaine-seeking behavior and anxiety-like behavior","volume":"17","author":"Pockros-Burgess","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib28","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s00213-015-3932-z","article-title":"Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys by direct and indirect activation of 5-HT2C receptors","volume":"232","author":"R\u00fcedi-Bettschen","year":"2015","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.heliyon.2024.e29979_bib29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ijnp\/pyz023","article-title":"Tropisetron Facilitates Footshock Suppression of compulsive cocaine seeking","volume":"22","author":"Zhou","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.1998.tb08217.x","article-title":"The serotonergic system modulates the cocaine-induced expression of the immediate early genes egr-1 and c-fos in rat brain","volume":"844","author":"Humblot","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.heliyon.2024.e29979_bib31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/syn.21592","article-title":"5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen","volume":"66","author":"Pockros","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.heliyon.2024.e29979_bib32","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1111\/j.1460-9568.2004.03805.x","article-title":"5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response, and behavioral sensitization to opiates and psychostimulants","volume":"20","author":"Auclair","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e29979_bib33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/adb.12137","article-title":"Serotonin2C receptors modulate dopamine transmission in the nucleus accumbens independently of dopamine release, behavioral, neurochemical and molecular studies with cocaine","volume":"20","author":"Cathala","year":"2015","journal-title":"Addict Biol"},{"key":"10.1016\/j.heliyon.2024.e29979_bib34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s002130050235","article-title":"5-HT3 receptor mediated dopamine release in the nucleus accumbens during withdrawal from continuous cocaine","volume":"130","author":"Matell","year":"1997","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.heliyon.2024.e29979_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0740-5472(95)00001-L","article-title":"Treatment of crack-cocaine-induced compulsive behavior with TRZ","volume":"12","author":"Khouzam","year":"1995","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.heliyon.2024.e29979_bib36","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1007\/s11469-021-00547-6","article-title":"Effect of MIR on craving in cocaine depended patients","volume":"20","author":"Nanni-Alvarado","year":"2022","journal-title":"Int. J. Ment. Health Addiction"},{"key":"10.1016\/j.heliyon.2024.e29979_bib37","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00004714-199412000-00005","article-title":"FLX alters the effects of intravenous cocaine in humans","volume":"14","author":"Walsh","year":"1994","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/00952990.2011.644002","article-title":"The efficacy of MIR in the treatment of cocaine dependence with comorbid depression","volume":"38","author":"Afshar","year":"2012","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.heliyon.2024.e29979_bib39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0376-8716(00)00208-8","article-title":"FLX treatment of cocaine-dependent patients with major depressive disorder","volume":"63","author":"Schmitz","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.heliyon.2024.e29979_bib40","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.genhosppsych.2007.01.015","article-title":"Cocaine use as a risk factor for ZPR-induced acute dystonia","volume":"29","author":"Duggal","year":"2007","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e29979_bib41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/ijnp\/pyaa065","article-title":"RIS and 5-HT2A receptor antagonists attenuate and Reverse cocaine-induced Hyperthermia in rats","volume":"23","author":"Okada","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib42","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.4088\/JCP.v67n1122c","article-title":"Beneficial effects of PRZ for visual hallucinations associated with chronic cocaine abuse","volume":"67","author":"Tapp","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e29979_bib43","first-page":"143","article-title":"A Randomized Controlled Trial Comparing the efficacy of low-dose amitriptyline, amitriptyline with PIN and surrogate placebo in the treatment of chronic tension-type facial pain","volume":"51","author":"Agius","year":"2013","journal-title":"Rhinology"},{"key":"10.1016\/j.heliyon.2024.e29979_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109074","article-title":"A randomized, double-blind, placebo-controlled trial of OND for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis","volume":"228","author":"Blevins","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.heliyon.2024.e29979_bib45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainresbull.2008.05.004","article-title":"Haloperidol (but not ZPR) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice","volume":"77","author":"Fukushiro","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.heliyon.2024.e29979_bib46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0091-3057(01)00657-8","article-title":"Inhibition of cocaine self-administration by FLX or D-fenfluramine combined with phentermine","volume":"71","author":"Glatz","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.heliyon.2024.e29979_bib47","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3390\/brainsci2040619","article-title":"The \u03b11 antagonist Doxazosin alters the behavioral effects of cocaine in rats","volume":"2","author":"Haile","year":"2012","journal-title":"Brain Sci."},{"key":"10.1016\/j.heliyon.2024.e29979_bib48","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1098\/rstb.2008.0089","article-title":"Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction","volume":"363","author":"Everitt","year":"2008","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.heliyon.2024.e29979_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/7854_2009_21","article-title":"Sensitization processes in drug addiction","volume":"3","author":"Vanderschuren","year":"2010","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.heliyon.2024.e29979_bib50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.psychres.2017.05.006","article-title":"Dose- and time-dependent effects of MIR on the expression of cocaine-induced behavioral sensitization in rats","volume":"254","author":"Barbosa-M\u00e9ndez","year":"2017","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.heliyon.2024.e29979_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/srep19796","article-title":"Pharmacological treatment with MIR rescues cortical atrophy and respiratory deficits in MeCP2 null mice","volume":"6","author":"Bittolo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2024.e29979_bib52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1590\/1516-4446-2016-2058","article-title":"Chronic dosing with MIR does not produce sedation in rats","volume":"39","author":"Salazar-Ju\u00e1rez","year":"2017","journal-title":"Braz J Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e29979_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pnpbp.2016.02.010","article-title":"MIR prevents induction and expression of cocaine-induced behavioral sensitization in rats","volume":"68","author":"Salazar-Ju\u00e1rez","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e29979_bib54","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejphar.2017.12.033","article-title":"MIR impairs acquisition and reinstatement of cocaine-induced place preference in rats","volume":"820","author":"Barbosa-M\u00e9ndez","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpsychires.2017.03.021","article-title":"MIR attenuates cocaine seeking in rats","volume":"92","author":"Barbosa-M\u00e9ndez","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.heliyon.2024.e29979_bib56","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0278-5846(03)00176-3","article-title":"Acute and subacute effects of RIS and cocaine on accumbens dopamine and serotonin release using in vivo microvoltammetry on line with open-field behavior","volume":"27","author":"Broderick","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e29979_bib57","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0028-3908(02)00381-7","article-title":"Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens","volume":"44","author":"Bubar","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.heliyon.2024.e29979_bib58","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbr.2012.01.056","article-title":"Reversal of cocaine withdrawal-induced anxiety by OND, buspirone and propranolol","volume":"231","author":"de Oliveira","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.heliyon.2024.e29979_bib59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00213-008-1317-2","article-title":"S(-)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats","volume":"203","author":"Young","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.heliyon.2024.e29979_bib60","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0091-3057(00)00290-2","article-title":"8-OH DPAT can restore the locomotor stimulant effects of cocaine blocked by haloperidol","volume":"66","author":"Carey","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.heliyon.2024.e29979_bib61","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.pnpbp.2007.01.025","article-title":"Haloperidol (but not ZPR) withdrawal enhances cocaine-induced locomotor activation and conditioned place preference in mice","volume":"31","author":"Fukushiro","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e29979_bib62","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.2042-7158.1989.tb06348.x","article-title":"Alpha 1-adrenoceptors, the ability of various agonists and antagonists to discriminate between two distinct [H]PRZ binding sites","volume":"41","author":"Hanft","year":"1989","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib63","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00213-012-2919-2","article-title":"Evaluation of chemically diverse 5-HT\u2082c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles","volume":"226","author":"Higgins","year":"2013","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.heliyon.2024.e29979_bib64","first-page":"542","article-title":"OND given in the acute withdrawal from a repeated cocaine sensitization dosing regimen reverses the expression of sensitization and inhibits self-administration","volume":"27","author":"Davidson","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.heliyon.2024.e29979_bib65","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1523\/JNEUROSCI.22-07-02873.2002","article-title":"Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates","volume":"22","author":"Drouin","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e29979_bib66","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/sj.npp.1300949","article-title":"Effects of atypical antipsychotic drugs on intralipid intake and cocaine-induced hyperactivity in rats","volume":"31","author":"Hartfield","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.heliyon.2024.e29979_bib67","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0741-8329(94)90032-9","article-title":"Comparison of the action of the 5-HT2 antagonists amperozide and TRZ on preference for alcohol in rats","volume":"11","author":"McMillen","year":"1994","journal-title":"Alcohol"},{"key":"10.1016\/j.heliyon.2024.e29979_bib68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.drugalcdep.2016.08.020","article-title":"Cocaine self-administration and reinstatement in female rats selectively bred for high and low voluntary running","volume":"167","author":"Smethells","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.heliyon.2024.e29979_bib69","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41386-018-0301-8","article-title":"Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice","volume":"44","author":"Stewart","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.heliyon.2024.e29979_bib70","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s00213-003-1747-9","article-title":"FLX, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine, possible pharmacokinetic effects","volume":"174","author":"Fletcher","year":"2004","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.heliyon.2024.e29979_bib71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1196\/annals.1369.026","article-title":"FLX as a potential pharmacotherapy for methamphetamine dependence, studies in mice","volume":"1074","author":"Takamatsu","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.heliyon.2024.e29979_bib72","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/FBP.0b013e3283242ff4","article-title":"The 5-HT3 receptor antagonist, OND, blocks the development and expression of ethanol-induced locomotor sensitization in mice","volume":"20","author":"Umathe","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib73","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(02)02616-X","article-title":"Cocaine-induced hypophagia and hyperlocomotion in rats are attenuated by PRZ","volume":"455","author":"Wellman","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib74","doi-asserted-by":"crossref","first-page":"454","DOI":"10.4306\/pi.2014.11.4.454","article-title":"Effects of Clozapine, haloperidol, and FLX on the reversal of cocaine-induced locomotor sensitization","volume":"11","author":"Cha","year":"2014","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.heliyon.2024.e29979_bib75","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1017\/S1461145713001430","article-title":"Selective action of an atypical neuroleptic on the mechanisms related to the development of cocaine addiction, a pre-clinical behavioural study","volume":"17","author":"Marinho","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib76","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pnpbp.2016.10.004","article-title":"Context-dependent efficacy of a counter-conditioning strategy with atypical neuroleptic drugs in mice previously sensitized to cocaine","volume":"73","author":"Oliveira-Lima","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e29979_bib80","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0091-3057(94)90135-X","article-title":"5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine","volume":"47","author":"King","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.heliyon.2024.e29979_bib77","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/WNR.0b013e32835ad246","article-title":"PRZ differentially affects extinction of cocaine conditioned place preference on the basis of dose and initial preference","volume":"23","author":"Bernardi","year":"2012","journal-title":"Neuroreport"},{"key":"10.1016\/j.heliyon.2024.e29979_bib78","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pbb.2008.07.012","article-title":"The alpha1adrenergic receptor antagonist PRZ reduces heroin self-administration in rats with extended access to heroin administration","volume":"91","author":"Greenwell","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.heliyon.2024.e29979_bib79","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.biopsych.2005.02.003","article-title":"PRZ, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking","volume":"57","author":"Zhang","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e29979_bib81","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.npp.1300007","article-title":"Neural activation profile elicited by cues associated with the anxiogenic drug YOH differs from that observed for reward-paired cues","volume":"28","author":"Schroeder","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.heliyon.2024.e29979_bib82","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejphar.2017.06.028","article-title":"MIR attenuates the expression of nicotine-induced locomotor sensitization in rats","volume":"812","author":"Barbosa-M\u00e9ndez","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib92","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jpsychires.2013.02.013","article-title":"Chronic administration of duloxetine and MIR downregulates proapoptotic proteins and upregulates neurotrophin gene expression in the hippocampus and cerebral cortex of mice","volume":"47","author":"Engel","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.heliyon.2024.e29979_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172539","article-title":"MIR increases glial cell line-derived neurotrophic factor production through lysophosphatidic acid 1 receptor-mediated extracellular signal-regulated kinase signaling in astrocytes","volume":"860","author":"Hisaoka-Nakashima","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib94","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77652-4","article-title":"MIR exerts astrocyte-mediated dopaminergic neuroprotection","volume":"10","author":"Kikuoka","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29979_bib95","first-page":"105","article-title":"Effect of repeated treatment with MIR on the central alpha1-adrenergic receptors","volume":"53","author":"Rogoz","year":"2002","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib96","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejphar.2005.09.069","article-title":"Repeated treatment with antidepressants enhances dopamine D1 receptor gene expression in the rat brain","volume":"532","author":"Huzarska","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib83","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0306-4522(02)00272-5","article-title":"Withdrawal duration differentially affects c-fos expression in the medial prefrontal cortex and discrete sub-regions of the nucleus accumbens in cocaine-sensitized rats","volume":"114","author":"Todtenkopf","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.heliyon.2024.e29979_bib84","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130000493","article-title":"Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization, a critical review of preclinical studies","volume":"151","author":"Vanderschuren","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.heliyon.2024.e29979_bib85","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of MIR","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.heliyon.2024.e29979_bib86","series-title":"The Neuroscience of Depression, Features, Diagnosis, and Treatment","first-page":"401","article-title":"MIR, Multi-target strategies for treating substance use disorder and depression","author":"Barbosa-M\u00e9ndez","year":"2021"},{"issue":"Suppl 4","key":"10.1016\/j.heliyon.2024.e29979_bib87","first-page":"19","article-title":"The pharmacologic profile of MIR","volume":"57","author":"de Boer","year":"1996","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e29979_bib88","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1460-9568.2000.00982.x","article-title":"MIR enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors, a comparison with citalopram","volume":"12","author":"Millan","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.heliyon.2024.e29979_bib89","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00023210-200923050-00006","article-title":"MIR, a review of its use in major depression and other psychiatric disorders","volume":"23","author":"Croom","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.heliyon.2024.e29979_bib90","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1124\/mol.107.041574","article-title":"Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors, differential modulation of cell surface expression and signal transduction","volume":"73","author":"Chanrion","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib91","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.brainresbull.2004.02.007","article-title":"MIR increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"63","author":"Nakayama","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.heliyon.2024.e29979_bib97","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12720","article-title":"Sexual cues influence cocaine-induced locomotion, anxiety and the immunoreactivity of oestrogen receptor alpha and tyrosine hydroxylase in both sexes","volume":"31","author":"He","year":"2019","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib98","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1037\/a0024798","article-title":"Psychomotor stimulant effects of cocaine in rats and 15 mouse strains","volume":"19","author":"Thomsen","year":"2011","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.heliyon.2024.e29979_bib99","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0091-3057(91)90054-6","article-title":"Sex differences in locomotor activity after acute and chronic cocaine administration","volume":"39","author":"Van Haaren","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.heliyon.2024.e29979_bib100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pbb.2007.04.023","article-title":"Intravenous cocaine self-administration, individual differences in male and female C57BL\/6J mice","volume":"87","author":"Griffin","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.heliyon.2024.e29979_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2020.104821","article-title":"Sex chromosome complement influences vulnerability to cocaine in mice","volume":"125","author":"Martini","year":"2020","journal-title":"Horm. Behav."},{"key":"10.1016\/j.heliyon.2024.e29979_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2020.104817","article-title":"MIR reduces the expression of cocaine-induced locomotor sensitization in male and female Wistar rats","volume":"125","author":"Barbosa-M\u00e9ndez","year":"2020","journal-title":"Horm. Behav."},{"key":"10.1016\/j.heliyon.2024.e29979_bib115","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s002130100917","article-title":"How does stress increase risk of drug abuse and relapse","volume":"158","author":"Sinha","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.heliyon.2024.e29979_bib116","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1196\/annals.1441.030","article-title":"Chronic stress, drug use, and vulnerability to addiction","volume":"1141","author":"Sinha","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.heliyon.2024.e29979_bib103","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1016\/j.bmc.2006.02.029","article-title":"Synthesis and biodistribution of [11C] R107474, a new radiolabeled alpha2-adrenoceptor antagonist","volume":"14","author":"Van der Mey","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.heliyon.2024.e29979_bib104","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00002018-199717040-00005","article-title":"A risk-benefit assessment of mirtazapine in the treatment of depression","volume":"17","author":"Kasper","year":"1997","journal-title":"Drug Saf."},{"key":"10.1016\/j.heliyon.2024.e29979_bib105","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/YIC.0000000000000035","article-title":"Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia","volume":"29","author":"Poyurovsky","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib106","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2005-864120","article-title":"Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice","volume":"38","author":"Grasmader","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.heliyon.2024.e29979_bib107","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1016\/S0924-977X(97)88520-3","article-title":"Tolerability of mirtazapine used in high or low initial dose","volume":"7","author":"Stahl","year":"1997","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.heliyon.2024.e29979_bib108","first-page":"82","article-title":"Mirtazapine safety and tolerability: analysis of the clinical trials database","volume":"96","author":"Stimmel","year":"1997","journal-title":"Prim Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e29979_bib109","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hup.2321","article-title":"Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers","volume":"28","author":"Sasada","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib110","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2147\/DDDT.S257494","article-title":"Potential Impact of the Multi-target drug approach in the treatment of some complex diseases","volume":"14","author":"Makhoba","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.heliyon.2024.e29979_bib111","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fphar.2015.00205","article-title":"Multi-target pharmacology, possibilities and limitations of the \"skeleton key approach\" from a medicinal chemist perspective","volume":"6","author":"Talevi","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib112","article-title":"Multi-target drugs, the trend of drug research and development","volume":"7","author":"Lu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2024.e29979_bib113","first-page":"381","article-title":"Effect of repeated treatment with MIR on the central dopaminergic D2\/D3 receptors","volume":"54","author":"Rogoz","year":"2002","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29979_bib114","first-page":"661","article-title":"Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats","volume":"56","author":"Rog\u00f3z","year":"2005","journal-title":"J. Physiol. Pharmacol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024060109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024060109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:16:02Z","timestamp":1775733362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024060109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":116,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2405844024060109"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29979","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of multitarget drugs on the expression of cocaine-induced locomotor sensitization in male rats: A comparative study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e29979"}}